Comparison

(KO Validated) LITAF Polyclonal Antibody

Item no. E-AB-60978-120
Manufacturer Elabscience
Amount 120 uL
Quantity options 120 uL 200 uL 60 uL
Category
Type Antibody Polyclonal
Applications WB, IHC
Specific against Human (Homo sapiens), Mouse (Murine, Mus musculus)
Host Rabbit
Isotype IgG
Conjugate/Tag Unconjugated
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias LITAF, PIG7, SIMPLE, TP53I7
Similar products LITAF, FLJ38636, MGC116698, MGC116700, MGC116701, MGC125274, MGC125275, MGC125276, PIG7, SIMPLE, TP53I7, LPS-induced TNF-alpha factor, Lipopolysaccharide-induced tumor necrosis factor-alpha factor, p53-induced gene 7 protein, CMT1C, Lipopolysaccharide induced TNF alpha factor, Lipopolysaccharide induced TNF factor, Lipopolysaccharide induced tumor necrosis factor alpha factor, LPS induced TNF alpha factor, p53 induced gene 7 protein, PIG 7, Small integral membrane protein of lysosome/late endosome, Tumor protein p53 inducible protein 7
Shipping Condition Cool pack
Hazard information Comply with cargo safety certificate
Available
Manufacturer - Category
Primary Antibodies
Manufacturer - Targets
LITAF
Shipping Temperature
The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.
Storage Conditions
Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Calculated Molecular Weight
15kDa/17kDa/23kDa
Observed Molecular Weight
20kDa
Manufacturer - Research Areas
Epigenetics and Nuclear Signaling, Signal Transduction
Background
Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene.
Concentration
1mg/mL
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification Method
Affinity purification
Recommended Dilution
WB 1:500-1:2000; IHC 1:50-1:200
Abbreviation
LITAF
Clonality
Polyclonal
Immunogen
Recombinant fusion protein of human LITAF (NP_004853.2).
Category ID III
Polyclonal Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 120 uL
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?